Volatile Anesthetic Protection Of Renal Transplants 2

NCT02727296 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 488

Last updated 2025-07-30

No results posted yet for this study

Summary

To compare the effect of a sevoflurane based anesthesia versus a propofol based anesthesia on the incidence of DGF in recipients of kidneys of donation after circulatory death (DCD) and donation after brain death (DBD) donors

Conditions

  • Delayed Graft Function
  • Renal Outcome After Kidney Transplantation
  • Acute Rejection (AR) of Transplanted Kidney
  • Graft Survival
  • Patient Survival
  • Postoperative Complications
  • Length of Hospital Stay
  • Primary Non Function

Interventions

DRUG

sevoflurane

General anesthesia with sevoflurane

DRUG

propofol

General anesthesia with propofol

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Gertrude J Nieuwenhuijs-Moeke, MD · University Medical Center Groningen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2025-01-30
Completion
2025-01-31

Countries

  • Denmark
  • Netherlands
  • Norway
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02727296 on ClinicalTrials.gov